These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of direction of head movement on motion sickness caused by Coriolis stimulation. Woodman PD; Griffin MJ Aviat Space Environ Med; 1997 Feb; 68(2):93-8. PubMed ID: 9125096 [TBL] [Abstract][Full Text] [Related]
6. Effects of motion sickness and antimotion sickness drugs on gastric function. Stewart JJ; Wood MJ; Wood CD; Mims ME J Clin Pharmacol; 1994 Jun; 34(6):635-43. PubMed ID: 8083395 [TBL] [Abstract][Full Text] [Related]
7. Various anti-motion sickness drugs and core body temperature changes. Cheung B; Nakashima AM; Hofer KD Aviat Space Environ Med; 2011 Apr; 82(4):409-15. PubMed ID: 21485398 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness and duration of intramuscular antimotion sickness medications. Wood CD; Stewart JJ; Wood MJ; Mims M J Clin Pharmacol; 1992 Nov; 32(11):1008-12. PubMed ID: 1474161 [TBL] [Abstract][Full Text] [Related]
9. Prokinetic effects of erythromycin after antimotion sickness drugs. Stewart JJ; Wood MJ; Parish RC; Wood CD J Clin Pharmacol; 2000 Apr; 40(4):347-53. PubMed ID: 10761161 [TBL] [Abstract][Full Text] [Related]
10. The effect of antimotion sickness drugs on habituation to motion. Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of low-dose intranasal scopolamine for motion sickness. Simmons RG; Phillips JB; Lojewski RA; Wang Z; Boyd JL; Putcha L Aviat Space Environ Med; 2010 Apr; 81(4):405-12. PubMed ID: 20377145 [TBL] [Abstract][Full Text] [Related]
12. Individual differences in susceptibility to motion sickness among six Skylab astronauts. Graybiel A; Miller EF; Homick JL Acta Astronaut; 1975; 2(1-2):155-74. PubMed ID: 11841091 [TBL] [Abstract][Full Text] [Related]
13. Mechanics of Coriolis stimulus and inducing factors of motion sickness. Isu N; Shimizu T; Sugata K Biol Sci Space; 2001 Dec; 15(4):414-9. PubMed ID: 12101369 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of phosphatidylcholine in the modulation of motion sickness susceptibility. Kohl RL; Ryan P; Homick JL Aviat Space Environ Med; 1985 Feb; 56(2):125-8. PubMed ID: 3985888 [TBL] [Abstract][Full Text] [Related]
16. Salivary total protein and experimental Coriolis sickness. Igarashi M; Reschke MF; Henley C; MacDonald S; Kohl R; Mizukoshi K Acta Otolaryngol Suppl; 1993; 504():38-40. PubMed ID: 8470530 [TBL] [Abstract][Full Text] [Related]
17. Use of promethazine to hasten adaptation to provocative motion. Lackner JR; Graybiel A J Clin Pharmacol; 1994 Jun; 34(6):644-8. PubMed ID: 8083396 [TBL] [Abstract][Full Text] [Related]
18. Autonomic function and plasma catecholamines following stressful sensory stimuli. Kohl RL Aviat Space Environ Med; 1993 Oct; 64(10):921-7. PubMed ID: 8240196 [TBL] [Abstract][Full Text] [Related]
19. The relation of motion sickness to the spatial-temporal properties of velocity storage. Dai M; Kunin M; Raphan T; Cohen B Exp Brain Res; 2003 Jul; 151(2):173-89. PubMed ID: 12783152 [TBL] [Abstract][Full Text] [Related]
20. Effects of ginger on motion sickness susceptibility and gastric function. Stewart JJ; Wood MJ; Wood CD; Mims ME Pharmacology; 1991; 42(2):111-20. PubMed ID: 2062873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]